In our latest Liberty Update, we highlight an eye-opening new study confirming how drug price controls…
CFIF on Twitter CFIF on YouTube
AEI's Michael Rosen: "Omicron Variant Sows Chaos but Doesn’t Move Needle on Patent Waiver Debate"

In our latest Liberty Update, we highlight an eye-opening new study confirming how drug price controls kill pharmaceutical investment and innovation at the worst possible time, when America and the entire world depend upon them more than ever.

In similar vein, American Enterprise Institute (AEI) Adjunct Fellow and healthcare expert Michael Rosen nicely illustrates how the omicron variant of Covid has paused the destructive global effort to suspend enforcement of patent rights belonging to lifesaving vaccine developers:

But the new omicron variant of the virus has intervened, shelving the planned WTO meeting and throwing into continued contrast the supposed haves and have-nots of vaccine protection...  But the EU has held firm in resisting the vaccine waiver, and rightly so."

Unfortunately…[more]

December 06, 2021 • 12:20 PM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
New Study Confirms How Drug Price Controls Kill Investment and Innovation
By Timothy H. Lee
Thursday, December 02 2021
Anyone who considers European healthcare a model to emulate or welcomes government drug price controls just received a jarring corrective in the form of a new study by VitalTransformation.   For example, as of 2019 late-stage biopharmaceutical venture capital funding in the European Union (EU) amounted to just 3% of the United States level.   That’s not a typo.  Three percent.   Additionally, biopharma startup investments in the EU – which include both internal domestic and foreign direct investments – totaled less than 10% of the U.S. level…
 
Third Worldizing America
In a recent online exchange, the YouTuber Casey Neistat posted his fury after his car was broken into…
Read more...
The Biden-Buttigieg Pitch: It's All Free!
The 2020 Democratic presidential primary campaign was essentially a bidding war in which each candidate…
Read more...
 
Fauci Puts Us at Risk
A new COVID-19 variant, reported from sub-Saharan Africa on Wednesday, has caused many developed countries…
Read more...
Losing Confidence In the Pillars of Our Civilization
Millions of citizens long ago concluded that professional sports, academia, and entertainment were no…
Read more...
 
For Democrats, the Word Is 'Transform'
Remember when Joe Biden ran for president in what commentators called the "centrist" lane of…
Read more...
There Will Be No Media 'Reckoning' Over the Steele Dossier
Axios says there's a "reckoning" in the media over coverage of the Steele dossier after the…
Read more...
 
Biden Administration Seeks to Kill the Moderna Goose that Laid the Golden Vaccine Egg
The same Biden Administration that seemed almost annoyed at having to evacuate desperate Americans from…
Read more...
Can the FBI be Salvaged?
The Washington, D.C.-based Federal Bureau of Investigation has lost all credibility as a disinterested…
Read more...
 
Here We Go Again: Another Federal Agency Interferes with the 5G Rollout
  It’s like Bill Murray’s movie “Groundhog Day,” but not nearly as funny.  …
Read more...
Court Blasts Biden's Anti-Work Vaccine Mandate
Working Americans got good news on Friday. They may not have to worry about getting laid off because…
Read more...
Quiz Question   
Which of the following is famously known as “a date which will live in infamy”?
More Questions
Notable Quote   
 
"As a member of Congress, Rep. Alexandria Ocasio-Cortez makes a whopping $174,000 annually, meaning that she individually earns more than twice the average U.S. household's income. Yet the progressive Democrat nonetheless thinks that working-class taxpayers should have to pay off her student loan debt.That's one of the main takeaways from Ocasio-Cortez's latest speech on the House floor. In the congresswoman…[more]
 
 
—Brad Polumbo, Freelance Writer
— Brad Polumbo, Freelance Writer
 
Liberty Poll   

In your Christmas shopping thus far, how are you faring?